Physician profile
Christopher B Hansen
NPI 1114077849
$545.37
in general payments reported to CMS, 2019-2025
6 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $76.99 · 2021: $72.00 · 2022: $13.55 · 2023: $94.50 · 2024: $92.76 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $348 · Food and Beverage: $35.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $347.56 |
| Food and Beverage | $35.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $400.97 | 2020-2025 | Tremfya, Stelara |
| Regeneron Healthcare Solutions, INC. | $95.58 | 2025 | Dupixent |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.76 | 2024 | Cabtreo |
| Abbvie INC. | $14.51 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $13.55 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.